img

Global Over The Counter (OTC) Drugs Market Size, Status and Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 105 | Industry : Pharma & Healthcare

Publisher : q | Format : PDF

Global Over The Counter (OTC) Drugs Market Size, Status and Forecast 2024-2034

Global Over The Counter (OTC) Drugs Scope and Market Size
Over The Counter (OTC) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Over The Counter (OTC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral, and Supplements (VMS)
Weight Loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Others


Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA




By Company


Bayer AG
Merck KGaA
Novartis
Johnson & Johnson
GlaxoSmithKline
Alkem Laboratories
Teva Pharmaceutical Industries
Pfizer
Sun Pharma
Allergan

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Analgesics
1.2.3 Dermatology Products
1.2.4 Gastrointestinal Products
1.2.5 Vitamins, Mineral, and Supplements (VMS)
1.2.6 Weight Loss/Dietary Products
1.2.7 Ophthalmic Products
1.2.8 Sleeping Aids
1.2.9 Others
1.3 Market by Application
1.3.1 Global Over The Counter (OTC) Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Over The Counter (OTC) Drugs Market Perspective (2016-2027)
2.2 Over The Counter (OTC) Drugs Growth Trends by Regions
2.2.1 Over The Counter (OTC) Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Over The Counter (OTC) Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Over The Counter (OTC) Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Over The Counter (OTC) Drugs Industry Dynamic
2.3.1 Over The Counter (OTC) Drugs Market Trends
2.3.2 Over The Counter (OTC) Drugs Market Drivers
2.3.3 Over The Counter (OTC) Drugs Market Challenges
2.3.4 Over The Counter (OTC) Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Over The Counter (OTC) Drugs Players by Revenue
3.1.1 Global Top Over The Counter (OTC) Drugs Players by Revenue (2016-2021)
3.1.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Over The Counter (OTC) Drugs Revenue
3.4 Global Over The Counter (OTC) Drugs Market Concentration Ratio
3.4.1 Global Over The Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Over The Counter (OTC) Drugs Revenue in 2020
3.5 Over The Counter (OTC) Drugs Key Players Head office and Area Served
3.6 Key Players Over The Counter (OTC) Drugs Product Solution and Service
3.7 Date of Enter into Over The Counter (OTC) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Over The Counter (OTC) Drugs Breakdown Data by Type
4.1 Global Over The Counter (OTC) Drugs Historic Market Size by Type (2016-2021)
4.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Type (2022-2027)

5 Over The Counter (OTC) Drugs Breakdown Data by Application
5.1 Global Over The Counter (OTC) Drugs Historic Market Size by Application (2016-2021)
5.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Over The Counter (OTC) Drugs Market Size (2016-2027)
6.2 North America Over The Counter (OTC) Drugs Market Size by Type
6.2.1 North America Over The Counter (OTC) Drugs Market Size by Type (2016-2021)
6.2.2 North America Over The Counter (OTC) Drugs Market Size by Type (2022-2027)
6.2.3 North America Over The Counter (OTC) Drugs Market Size by Type (2016-2027)
6.3 North America Over The Counter (OTC) Drugs Market Size by Application
6.3.1 North America Over The Counter (OTC) Drugs Market Size by Application (2016-2021)
6.3.2 North America Over The Counter (OTC) Drugs Market Size by Application (2022-2027)
6.3.3 North America Over The Counter (OTC) Drugs Market Size by Application (2016-2027)
6.4 North America Over The Counter (OTC) Drugs Market Size by Country
6.4.1 North America Over The Counter (OTC) Drugs Market Size by Country (2016-2021)
6.4.2 North America Over The Counter (OTC) Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Over The Counter (OTC) Drugs Market Size (2016-2027)
7.2 Europe Over The Counter (OTC) Drugs Market Size by Type
7.2.1 Europe Over The Counter (OTC) Drugs Market Size by Type (2016-2021)
7.2.2 Europe Over The Counter (OTC) Drugs Market Size by Type (2022-2027)
7.2.3 Europe Over The Counter (OTC) Drugs Market Size by Type (2016-2027)
7.3 Europe Over The Counter (OTC) Drugs Market Size by Application
7.3.1 Europe Over The Counter (OTC) Drugs Market Size by Application (2016-2021)
7.3.2 Europe Over The Counter (OTC) Drugs Market Size by Application (2022-2027)
7.3.3 Europe Over The Counter (OTC) Drugs Market Size by Application (2016-2027)
7.4 Europe Over The Counter (OTC) Drugs Market Size by Country
7.4.1 Europe Over The Counter (OTC) Drugs Market Size by Country (2016-2021)
7.4.2 Europe Over The Counter (OTC) Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size (2016-2027)
8.2 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Type
8.2.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Application
8.3.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region
8.4.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Over The Counter (OTC) Drugs Market Size (2016-2027)
9.2 Latin America Over The Counter (OTC) Drugs Market Size by Type
9.2.1 Latin America Over The Counter (OTC) Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Over The Counter (OTC) Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Over The Counter (OTC) Drugs Market Size by Type (2016-2027)
9.3 Latin America Over The Counter (OTC) Drugs Market Size by Application
9.3.1 Latin America Over The Counter (OTC) Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Over The Counter (OTC) Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Over The Counter (OTC) Drugs Market Size by Application (2016-2027)
9.4 Latin America Over The Counter (OTC) Drugs Market Size by Country
9.4.1 Latin America Over The Counter (OTC) Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Over The Counter (OTC) Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size (2016-2027)
10.2 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Type
10.2.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Application
10.3.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country
10.4.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Over The Counter (OTC) Drugs Introduction
11.1.4 Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Over The Counter (OTC) Drugs Introduction
11.2.4 Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.2.5 Merck KGaA Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Over The Counter (OTC) Drugs Introduction
11.3.4 Novartis Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Over The Counter (OTC) Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Alkem Laboratories
11.6.1 Alkem Laboratories Company Details
11.6.2 Alkem Laboratories Business Overview
11.6.3 Alkem Laboratories Over The Counter (OTC) Drugs Introduction
11.6.4 Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.6.5 Alkem Laboratories Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Details
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.7.5 Teva Pharmaceutical Industries Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Over The Counter (OTC) Drugs Introduction
11.8.4 Pfizer Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.8.5 Pfizer Recent Development
11.9 Sun Pharma
11.9.1 Sun Pharma Company Details
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma Over The Counter (OTC) Drugs Introduction
11.9.4 Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.9.5 Sun Pharma Recent Development
11.10 Allergan
11.10.1 Allergan Company Details
11.10.2 Allergan Business Overview
11.10.3 Allergan Over The Counter (OTC) Drugs Introduction
11.10.4 Allergan Revenue in Over The Counter (OTC) Drugs Business (2016-2021)
11.10.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Analgesics
Table 3. Key Players of Dermatology Products
Table 4. Key Players of Gastrointestinal Products
Table 5. Key Players of Vitamins, Mineral, and Supplements (VMS)
Table 6. Key Players of Weight Loss/Dietary Products
Table 7. Key Players of Ophthalmic Products
Table 8. Key Players of Sleeping Aids
Table 9. Key Players of Others
Table 10. Global Over The Counter (OTC) Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Over The Counter (OTC) Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Over The Counter (OTC) Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Over The Counter (OTC) Drugs Market Share by Regions (2016-2021)
Table 14. Global Over The Counter (OTC) Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Over The Counter (OTC) Drugs Market Share by Regions (2022-2027)
Table 16. Over The Counter (OTC) Drugs Market Trends
Table 17. Over The Counter (OTC) Drugs Market Drivers
Table 18. Over The Counter (OTC) Drugs Market Challenges
Table 19. Over The Counter (OTC) Drugs Market Restraints
Table 20. Global Over The Counter (OTC) Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Over The Counter (OTC) Drugs Market Share by Players (2016-2021)
Table 22. Global Top Over The Counter (OTC) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over The Counter (OTC) Drugs as of 2020)
Table 23. Ranking of Global Top Over The Counter (OTC) Drugs Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Over The Counter (OTC) Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Over The Counter (OTC) Drugs Product Solution and Service
Table 27. Date of Enter into Over The Counter (OTC) Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Over The Counter (OTC) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2016-2021)
Table 31. Global Over The Counter (OTC) Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Over The Counter (OTC) Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2016-2021)
Table 35. Global Over The Counter (OTC) Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Over The Counter (OTC) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Over The Counter (OTC) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Over The Counter (OTC) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Over The Counter (OTC) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Over The Counter (OTC) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Over The Counter (OTC) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Over The Counter (OTC) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Over The Counter (OTC) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Over The Counter (OTC) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Over The Counter (OTC) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Over The Counter (OTC) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Over The Counter (OTC) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Over The Counter (OTC) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Over The Counter (OTC) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Over The Counter (OTC) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Over The Counter (OTC) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Over The Counter (OTC) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Over The Counter (OTC) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Over The Counter (OTC) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Over The Counter (OTC) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Over The Counter (OTC) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Over The Counter (OTC) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Over The Counter (OTC) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Over The Counter (OTC) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Over The Counter (OTC) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Over The Counter (OTC) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 67. Bayer AG Company Details
Table 68. Bayer AG Business Overview
Table 69. Bayer AG Over The Counter (OTC) Drugs Product
Table 70. Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2016-2021) & (US$ Million)
Table 71. Bayer AG Recent Development
Table 72. Merck KGaA Company Details
Table 73. Merck KGaA Business Overview
Table 74. Merck KGaA Over The Counter (OTC) Drugs Product
Table 75. Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2016-2021) & (US$ Million)
Table 76. Merck KGaA Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Over The Counter (OTC) Drugs Product
Table 80. Novartis Revenue in Over The Counter (OTC) Drugs Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Over The Counter (OTC) Drugs Product
Table 85. Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2016-2021) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Over The Counter (OTC) Drugs Product
Table 90. GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2016-2021) & (US$ Million)
Table 91. GlaxoSmithKline Recent Development
Table 92. Alkem Laboratories Company Details
Table 93. Alkem Laboratories Business Overview
Table 94. Alkem Laboratories Over The Counter (OTC) Drugs Product
Table 95. Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2016-2021) & (US$ Million)
Table 96. Alkem Laboratories Recent Development
Table 97. Teva Pharmaceutical Industries Company Details
Table 98. Teva Pharmaceutical Industries Business Overview
Table 99. Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Product
Table 100. Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2016-2021) & (US$ Million)
Table 101. Teva Pharmaceutical Industries Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Revenue in Over The Counter (OTC) Drugs Business (2016-2021) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Sun Pharma Company Details
Table 107. Sun Pharma Business Overview
Table 108. Sun Pharma Over The Counter (OTC) Drugs Product
Table 109. Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2016-2021) & (US$ Million)
Table 110. Sun Pharma Recent Development
Table 111. Allergan Company Details
Table 112. Allergan Business Overview
Table 113. Allergan Over The Counter (OTC) Drugs Product
Table 114. Allergan Revenue in Over The Counter (OTC) Drugs Business (2016-2021) & (US$ Million)
Table 115. Allergan Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Over The Counter (OTC) Drugs Market Share by Type: 2020 VS 2027
Figure 2. Analgesics Features
Figure 3. Dermatology Products Features
Figure 4. Gastrointestinal Products Features
Figure 5. Vitamins, Mineral, and Supplements (VMS) Features
Figure 6. Weight Loss/Dietary Products Features
Figure 7. Ophthalmic Products Features
Figure 8. Sleeping Aids Features
Figure 9. Others Features
Figure 10. Global Over The Counter (OTC) Drugs Market Share by Application: 2020 VS 2027
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Online Pharmacy Case Studies
Figure 14. Others Case Studies
Figure 15. Over The Counter (OTC) Drugs Report Years Considered
Figure 16. Global Over The Counter (OTC) Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Over The Counter (OTC) Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Over The Counter (OTC) Drugs Market Share by Regions: 2020 VS 2027
Figure 19. Global Over The Counter (OTC) Drugs Market Share by Regions (2022-2027)
Figure 20. Global Over The Counter (OTC) Drugs Market Share by Players in 2020
Figure 21. Global Top Over The Counter (OTC) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over The Counter (OTC) Drugs as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Over The Counter (OTC) Drugs Revenue in 2020
Figure 23. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2016-2021)
Figure 24. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2022-2027)
Figure 25. North America Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Over The Counter (OTC) Drugs Market Share by Type (2016-2027)
Figure 27. North America Over The Counter (OTC) Drugs Market Share by Application (2016-2027)
Figure 28. North America Over The Counter (OTC) Drugs Market Share by Country (2016-2027)
Figure 29. United States Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Over The Counter (OTC) Drugs Market Share by Type (2016-2027)
Figure 33. Europe Over The Counter (OTC) Drugs Market Share by Application (2016-2027)
Figure 34. Europe Over The Counter (OTC) Drugs Market Share by Country (2016-2027)
Figure 35. Germany Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Over The Counter (OTC) Drugs Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Over The Counter (OTC) Drugs Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Over The Counter (OTC) Drugs Market Share by Region (2016-2027)
Figure 45. China Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Over The Counter (OTC) Drugs Market Share by Type (2016-2027)
Figure 53. Latin America Over The Counter (OTC) Drugs Market Share by Application (2016-2027)
Figure 54. Latin America Over The Counter (OTC) Drugs Market Share by Country (2016-2027)
Figure 55. Mexico Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Over The Counter (OTC) Drugs Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Over The Counter (OTC) Drugs Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Over The Counter (OTC) Drugs Market Share by Country (2016-2027)
Figure 61. Turkey Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Over The Counter (OTC) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Bayer AG Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2016-2021)
Figure 65. Merck KGaA Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2016-2021)
Figure 68. GlaxoSmithKline Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2016-2021)
Figure 69. Alkem Laboratories Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2016-2021)
Figure 70. Teva Pharmaceutical Industries Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2016-2021)
Figure 72. Sun Pharma Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2016-2021)
Figure 73. Allergan Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed